Although all of the patents and exclusivity rights for Orap (pimozide) have expired, companies have not chosen to make a generic version of this medication. It is not clear why this is the case; it may be because the demand for a generic Orap is too small to make it profitable for a manufacturer to make a generic version.
Can I Buy Generic Orap?Orap® (pimozide) is a prescription medication prescribed to suppress motor and verbal tics in people with Tourette syndrome. It is reserved for use in people who have already tried another medication.
Orap is made by Teva Pharmaceuticals USA for Gate Pharmaceuticals. Although it is no longer protected from generic competition by patents, a generic version of Orap is not available.
When Will a Generic Version Be Available?Orap was originally approved by the U.S. Food and Drug Administration (FDA) in 1984. There are currently no unexpired patents or exclusivity rights protecting the drug from generic competition. Therefore, a manufacturer could make a generic version of the medication. However, at this point, no manufacturer has chosen to do so.
It is not entirely clear why a generic Orap has not been made. It could be that the demand for the medication is too small for a manufacturer to make a generic version. Because it is unknown why a generic version of Orap has not been made, it is impossible to predict when, or even if, a generic version might become available.
Is Pimozide a Generic Orap?No -- pimozide is the active ingredient in Orap, but is not a generic version of it. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.